| BID | 5.80 | ASK | 6.51 | ||
| Open | 6.24 | Previous Close | 6.17 | ||
| Pre-Market | 6.21 | After-Market | - | ||
| -0.23 -3.57% | - - |
| Target Price | 9.38 | Analyst Rating | Strong Buy 1.40 | |
| Potential % | 45.65 | Finscreener Ranking | — - | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★★★★+ 60.14 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★★★ 49.71 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | 104.12 | Earnings Rating | Strong Buy | |
| Market Cap | 106.43M | Earnings Date | 15th Nov 2023 | |
| Alpha | -0.01 | Standard Deviation | 0.17 | |
| Beta | 0.89 |
Today's Price Range 6.176.85 | 52W Range 1.386.24 |
Summary:
Buy
| Technical Indicators: | Neutral |
| Moving Averages: | Strong Buy |
| Performance | |||
|---|---|---|---|
| 1 Week | 16.88% | ||
| 1 Month | 92.81% | ||
| 3 Months | 96.94% | ||
| 6 Months | 295.09% | ||
| 1 Year | 216.41% | ||
| 3 Years | -0.46% | ||
| 5 Years | - | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -22.78 | |||
ROE last 12 Months | -20.21 | |||
ROA (5Y Avg) | -5.94 | |||
ROA last 12 Months | -15.28 | |||
ROC (5Y Avg) | -27.00 | |||
ROC last 12 Months | -20.63 | |||
Return on invested Capital Q | -9.71 | |||
Return on invested Capital Y | -3.53 | |||
Assets Turnover | 0.10 | |||
Receivables Turnover | 1.10 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -3.60 | ||||
| 0.78 | ||||
| 1.80 | ||||
| 96.00 | ||||
| -5.10 | ||||
| -0.24 | ||||
| 0.78 | ||||
| 2.96 | ||||
| -18 579 600.00 | ||||
| Forward PE | -38.86 | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 6.30 | ||||
| 6.80 | ||||
| 0.00 | ||||
| 0.01 | ||||
| 48.80 | ||||
| Leverage Ratio | 1.30 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 75.30 | ||||
| -37.70 | ||||
| -32.20 | ||||
| -35.90 | ||||
| -44.84 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 21.14M | ||||
| 1.28 | ||||
| - | ||||
| - |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q02 2023 | -0.17 | -0.05 | 70.59 |
| Q01 2023 | -0.12 | -0.07 | 41.67 |
| Q04 2022 | -0.12 | -0.12 | 0.00 |
| Q03 2022 | -0.07 | -0.15 | -114.29 |
| Q02 2022 | -0.08 | -0.07 | 12.50 |
| Q01 2022 | -0.09 | -0.06 | 33.33 |
| Q04 2021 | -0.06 | -0.04 | 33.33 |
| Q03 2021 | -0.06 | -0.05 | 16.67 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 12/2023 QR | -0.03 | 25.00 | Positive |
| 12/2023 FY | -0.25 | 30.56 | Positive |
| 3/2024 QR | -0.06 | 25.00 | Positive |
| 12/2024 FY | -0.15 | 34.78 | Positive |
| Next Report Date | - |
| Estimated EPS Next Report | -0.09 |
| Estimates Count | 4 |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 295.69K |
| Shares Outstanding | 16.53K |
| Shares Float | 12.70M |
| Trades Count | 1.97K |
| Dollar Volume | 1.89M |
| Avg. Volume | 206.64K |
| Avg. Weekly Volume | 361.65K |
| Avg. Monthly Volume | 146.38K |
| Avg. Quarterly Volume | 111.89K |
Brainsway Ltd. (NASDAQ: BWAY) stock closed at 6.44 per share at the end of the most recent trading day (a 4.38% change compared to the prior day closing price) with a volume of 295.69K shares and market capitalization of 106.43M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 107 people. Brainsway Ltd. CEO is Christopher Richard von Jako.
The one-year performance of Brainsway Ltd. stock is 216.41%, while year-to-date (YTD) performance is 160.73%. BWAY stock has a five-year performance of %. Its 52-week range is between 1.38 and 6.24, which gives BWAY stock a 52-week price range ratio of 104.12%
Brainsway Ltd. currently has a PE ratio of -3.60, a price-to-book (PB) ratio of 0.78, a price-to-sale (PS) ratio of 1.80, a price to cashflow ratio of 96.00, a PEG ratio of -, a ROA of -15.28%, a ROC of -20.63% and a ROE of -20.21%. The company’s profit margin is -44.84%, its EBITDA margin is -32.20%, and its revenue ttm is $21.14 Million , which makes it $1.28 revenue per share.
Of the last four earnings reports from Brainsway Ltd., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.09 for the next earnings report. Brainsway Ltd.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Brainsway Ltd. is Strong Buy (1.4), with a target price of $9.38, which is +45.65% compared to the current price. The earnings rating for Brainsway Ltd. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Brainsway Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Brainsway Ltd. has a Buy technical analysis rating based on Technical Indicators (ADX : 17.87, ATR14 : 0.38, CCI20 : 173.12, Chaikin Money Flow : 0.13, MACD : 0.62, Money Flow Index : 92.18, ROC : 61.40, RSI : 84.29, STOCH (14,3) : 86.69, STOCH RSI : 1.00, UO : 59.86, Williams %R : -13.31), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Brainsway Ltd. in the last 12-months were:
Brainsway Ltd.
Brainsway Ltd is an Israel based company engaged in the business of developing and providing advanced technology solutions for the treatment of a variety of brain disorders. Its flagship technology is based on Deep Transcranial Magnetic Stimulation (TMS) which is used for brain disorder treatment such as treatment of depression in patients. The group earns revenues from the sale and lease of devices. It has a business presence in Israel and other foreign countries.
CEO: Christopher Richard von Jako
Telephone: +972 25813140
Address: 19 Hartum Street, Jerusalem 9777518, , IL
Number of employees: 107
